HK1009400A1 - Combination drug containing tramadol and a calcium channel antagonist - Google Patents

Combination drug containing tramadol and a calcium channel antagonist

Info

Publication number
HK1009400A1
HK1009400A1 HK98110443A HK98110443A HK1009400A1 HK 1009400 A1 HK1009400 A1 HK 1009400A1 HK 98110443 A HK98110443 A HK 98110443A HK 98110443 A HK98110443 A HK 98110443A HK 1009400 A1 HK1009400 A1 HK 1009400A1
Authority
HK
Hong Kong
Prior art keywords
calcium channel
channel antagonist
drug containing
combination drug
containing tramadol
Prior art date
Application number
HK98110443A
Other languages
English (en)
Inventor
Wolfgang Siegfried Reimann
Original Assignee
Gruenenthal Chemie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Chemie filed Critical Gruenenthal Chemie
Publication of HK1009400A1 publication Critical patent/HK1009400A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK98110443A 1996-10-09 1998-09-04 Combination drug containing tramadol and a calcium channel antagonist HK1009400A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19641576A DE19641576C1 (de) 1996-10-09 1996-10-09 Kombinationspräparat enthaltend Tramadol und einen Calcium-Kanal Antagonisten

Publications (1)

Publication Number Publication Date
HK1009400A1 true HK1009400A1 (en) 1999-06-04

Family

ID=7808249

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98110443A HK1009400A1 (en) 1996-10-09 1998-09-04 Combination drug containing tramadol and a calcium channel antagonist

Country Status (13)

Country Link
US (1) US5929122A (xx)
EP (1) EP0835656B1 (xx)
JP (1) JPH10147520A (xx)
AT (1) ATE209485T1 (xx)
AU (1) AU726341B2 (xx)
CA (1) CA2217846A1 (xx)
DE (2) DE19641576C1 (xx)
DK (1) DK0835656T3 (xx)
ES (1) ES2168562T3 (xx)
HK (1) HK1009400A1 (xx)
HU (1) HUP9701618A3 (xx)
PT (1) PT835656E (xx)
SI (1) SI0835656T1 (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002074241A2 (en) 2001-03-16 2002-09-26 Dmi Biosciences Inc. Method of delaying ejaculation
US8128957B1 (en) 2002-02-21 2012-03-06 Valeant International (Barbados) Srl Modified release compositions of at least one form of tramadol
US20050182056A9 (en) * 2002-02-21 2005-08-18 Seth Pawan Modified release formulations of at least one form of tramadol
DE10227511A1 (de) * 2002-06-19 2004-01-08 Max-Delbrück-Centrum für Molekulare Medizin Mittel zur medikamentösen Behandlung von akuten und chronischen Schmerzen
US20040248979A1 (en) * 2003-06-03 2004-12-09 Dynogen Pharmaceuticals, Inc. Method of treating lower urinary tract disorders
CA2603926A1 (en) * 2005-04-08 2006-10-12 Neuromed Pharmaceuticals Ltd. Combination therapy comprising an n-type calcium channel blocker for the alleviation of pain
PL387984A1 (pl) * 2009-05-07 2010-11-08 Instytut Medycyny Doświadczalnej I Klinicznej Im. Mirosława Mossakowskiego Pan Nowe kompozycje substancji leczniczych do leczenia bólów przewlekłych

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69215316T2 (de) * 1991-09-06 1997-03-20 Mcneilab Inc Zusammensetzungen, die Tramadol und irgendein Kodein, Oxykoden oder Hydrokoden enthalten, und deren Verwendung
AU651247B2 (en) * 1991-09-06 1994-07-14 Mcneilab, Inc. Composition comprising a tramadol material and acetaminophen and its use
AU661723B2 (en) * 1991-10-30 1995-08-03 Mcneilab, Inc. Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug

Also Published As

Publication number Publication date
HUP9701618A2 (hu) 1999-01-28
DE19641576C1 (de) 1998-05-07
MX9707719A (es) 1998-06-30
CA2217846A1 (en) 1998-04-09
HUP9701618A3 (en) 1999-10-28
DE59705525D1 (de) 2002-01-10
US5929122A (en) 1999-07-27
ES2168562T3 (es) 2002-06-16
JPH10147520A (ja) 1998-06-02
SI0835656T1 (en) 2002-08-31
EP0835656A1 (de) 1998-04-15
PT835656E (pt) 2002-05-31
DK0835656T3 (da) 2002-02-11
AU726341B2 (en) 2000-11-02
AU3998497A (en) 1998-04-23
ATE209485T1 (de) 2001-12-15
EP0835656B1 (de) 2001-11-28

Similar Documents

Publication Publication Date Title
AU1507597A (en) Blends containing absorbable polyoxaamides
HUP9900605A3 (en) Lipopolyamines as transfection agents, preparation and use thereof and pharmaceutical compositions containing them
HUP9700322A3 (en) Formulations and methods for providing prolonged local anesthesia
IL126655A0 (en) An oral pharmaceutical formulation containing ibandronate
EP0943327A4 (en) DRUG
HUP9701194A3 (en) 4-hydroxy-piperidine derivatives, preparation and use thereof, pharmaceutical compositions containing these compounds
GB2257611B (en) Improvements in surgical slippers for animals
EP0640097A4 (en) COMPOSITION AND METHODS FOR VACCINATING AGAINST CORONAVIRES (01/20/94).
IL128058A0 (en) Illudin analogs and pharmaceutical compositions containing the same
HUP0003840A3 (en) Controlled released medical formulation
PL322526A1 (en) Azathiopyrin compositions for intracolic administration
HUT71131A (en) Paramycin formulations for oral administration
HUP0004665A3 (en) Anaesthetic formulation
HK1009400A1 (en) Combination drug containing tramadol and a calcium channel antagonist
AU4667396A (en) Effervescent composition containing iodinated polyvinylpyrrolidone, and use thereof for disinfection
IL108624A0 (en) Pseudopeptides, their preparation and pharmaceutical compositions containing them
CY2293B1 (en) Slow-release pharmaceutical formulations containing mizolastin
HUP9903649A3 (en) Taxane derivatives, the preparation thereof and medical formulations containing them
HUP9602024A3 (en) Pharmaceutical composition containing aminoacid for external use
PL322170A1 (en) Mixed herbicide composition
AU4567997A (en) Formulations containing phosphatidylethanolamine
IL101890A0 (en) Non-stinging vaccine composition
SI1032390T1 (en) Anaesthetic formulation
SI0906101T1 (en) Slow-release pharmaceutical formulations containing mizolastin
ZA9810587B (en) Anaesthetic formulation.

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20060917